Systemic silencing of PHD2 causes reversible immune regulatory dysfunction

Yamamoto A., Hester J., Macklin PS., Kawai K., Uchiyama M., Biggs D., Bishop T., Bull K., Cheng X., Cawthorne E., Coleman ML., Crockford TL., Davies B., Dow LE., Goldin R., Kranc K., Kudo H., Lawson H., McAuliffe J., Milward K., Scudamore CL., Soilleux E., Issa F., Ratcliffe PJ., Pugh CW.

DOI

10.1172/jci124099

Type

Journal article

Journal

Journal of Clinical Investigation

Publisher

American Society for Clinical Investigation

Publication Date

04/06/2019

Permalink Original publication